https://www.selleckchem.com/EGFR(HER).html
327). The Kaplan-Meyer Survival analysis was performed, and there were no differences between the groups before 31.5 weeks. Logistic regression showed that a previous PB ( 37 weeks) presented an odds ratio (OR) of 15.951 (95% confidence interval [95%CI] 1.294-196.557;  = 0.031*) for PB  34 weeks in the PPG.  In DC-DA twin pregnancies with a short cervix, (which means a higher risk of P, the treatment with cervical pessary plus progesterone could be considered equivalent in several aspects related to PB in the NTG, despite the big dif

https://www.selleckchem.com/Bcl-2.html
The SARS-CoV-2 main protease (M pro ) is a major therapeutic target. The M pro inhibitor, nirmatrelvir, is the antiviral component of Paxlovid, an orally available treatment for COVID-19. As M pro inhibitor use increases, drug resistant mutations will likely emerge. We have established a non-pathogenic system, in which yeast growth serves as a proxy for M pro activity, enabling rapid identification of mutants with altered enzymatic activity and drug sensitivity. The E166 residue is known to be a potential hot spot for drug resistance and yeast ass